Living with severe & eosinophilic asthma is a new syndicated report which offers valuable insights into patient attitudes and behaviour. The EU study was conducted amongst 118 patients with diagnosis and/or confirmed characteristics of severe asthma (SA) or eosinophilic asthma (EA) in France and Germany. The US study was conducted with 105 SA and EA patients. For both studies the methodologies consisted of 30-minute quantitative online interviews and a small sample of 30-minute qualitative add-on telephone interviews. The Japan report will also be available to purchase over the coming weeks.
Asthma remains relatively under-diagnosed and under-treated, especially for the 5-10% of asthma patients considered "severe" who experience frequent exacerbations, despite maximal inhaled therapy. There has been much activity in this therapy area, with the recent launch of IL-5 biologics as well as biologic, non-biologic and biosimilar products expected to be launched in the near future. At this juncture, it is especially critical to understand the perspectives of patients with regard to living with severe asthma and eosinophilic asthma, its impact on their lives and what they seek in new treatments.
The reports enable pharmaceutical companies to gain an in-depth understanding of the patient journey, from diagnosis through to ongoing management of living with severe & eosinophilic asthma. Through these reports, you will understand how these conditions impacts patients’ lives physically and emotionally, what their level of understanding is about their condition and what unmet needs patients have related to its treatment and overall management.
Research Partnership has also recently launched new reports in Ulcerative Colitis and Crohn’s Disease covering markets across the EU, US and Japan. To find out more about these new reports or to request an information pack please contact us now.
Head of Living With, Mariel Metcalfe commented, “Research Partnership is committed to producing research which focuses on the voice of the patient, and to offer a more patient-centric view of what it is like to live with a long-term, life-changing illness. Our reports cover a wide range of therapy areas from Autoimmune, Dermatology and Gastroenterology, and we hope to expand the list of therapy areas year on year.”
To discover more, download our new interactive infographic to unlock key insights from various Living With reports to reveal patient behaviours, attitudes and unmet needs at different stages of their chronic disease journey. Download the infographic »
Sample HubSpot User
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using 'Content here, content here', making it look like readable English.
